ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,277 | -35.4% | 2,103 | -3.2% | 0.00% | -33.3% |
| Q2 2023 | $387,206 | +1.7% | 2,173 | -5.8% | 0.00% | 0.0% |
| Q1 2023 | $380,562 | +3.5% | 2,307 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $367,715 | +0.7% | 2,335 | -3.5% | 0.00% | 0.0% |
| Q3 2022 | $365,000 | -14.5% | 2,419 | -6.9% | 0.00% | 0.0% |
| Q2 2022 | $427,000 | -47.0% | 2,597 | -28.3% | 0.00% | -50.0% |
| Q1 2022 | $806,000 | +13.2% | 3,620 | +20.7% | 0.01% | +20.0% |
| Q4 2021 | $712,000 | +6.6% | 3,000 | +4.9% | 0.01% | 0.0% |
| Q3 2021 | $668,000 | +9.0% | 2,861 | -3.9% | 0.01% | +25.0% |
| Q2 2021 | $613,000 | +1.7% | 2,976 | +1.4% | 0.00% | -20.0% |
| Q1 2021 | $603,000 | -8.5% | 2,935 | -4.4% | 0.01% | 0.0% |
| Q4 2020 | $659,000 | -10.5% | 3,071 | -23.6% | 0.01% | -28.6% |
| Q3 2020 | $736,000 | +20.7% | 4,022 | +21.5% | 0.01% | +16.7% |
| Q2 2020 | $610,000 | -40.1% | 3,309 | -34.5% | 0.01% | -50.0% |
| Q1 2020 | $1,019,000 | +13.1% | 5,050 | +4.9% | 0.01% | +33.3% |
| Q4 2019 | $901,000 | +1.5% | 4,816 | -13.5% | 0.01% | 0.0% |
| Q3 2019 | $888,000 | -71.9% | 5,565 | -55.6% | 0.01% | -74.3% |
| Q2 2019 | $3,158,000 | +12.9% | 12,535 | +7.3% | 0.04% | +6.1% |
| Q1 2019 | $2,797,000 | +9.1% | 11,687 | +4.7% | 0.03% | 0.0% |
| Q4 2018 | $2,563,000 | -9.0% | 11,162 | +12.1% | 0.03% | -2.9% |
| Q3 2018 | $2,815,000 | +78.7% | 9,955 | +85.6% | 0.03% | +70.0% |
| Q2 2018 | $1,575,000 | -48.3% | 5,364 | -55.6% | 0.02% | 0.0% |
| Q1 2018 | $3,048,000 | +132.7% | 12,076 | +99.1% | 0.02% | +17.6% |
| Q4 2017 | $1,310,000 | +15.1% | 6,065 | -1.0% | 0.02% | +13.3% |
| Q3 2017 | $1,138,000 | +7.8% | 6,125 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $1,056,000 | +15.4% | 6,125 | +2.3% | 0.02% | +15.4% |
| Q1 2017 | $915,000 | +3.2% | 5,990 | -0.6% | 0.01% | 0.0% |
| Q4 2016 | $887,000 | +13.6% | 6,025 | -2.5% | 0.01% | +8.3% |
| Q3 2016 | $781,000 | +12.1% | 6,180 | 0.0% | 0.01% | +9.1% |
| Q2 2016 | $697,000 | +8.6% | 6,180 | +0.2% | 0.01% | 0.0% |
| Q1 2016 | $642,000 | -7.0% | 6,165 | +0.8% | 0.01% | -8.3% |
| Q4 2015 | $690,000 | +3.0% | 6,115 | -0.1% | 0.01% | 0.0% |
| Q3 2015 | $670,000 | -5.4% | 6,120 | -17.4% | 0.01% | +9.1% |
| Q2 2015 | $708,000 | -0.4% | 7,405 | -3.0% | 0.01% | 0.0% |
| Q1 2015 | $711,000 | +11.4% | 7,635 | -1.9% | 0.01% | +10.0% |
| Q4 2014 | $638,000 | +25.6% | 7,785 | -1.7% | 0.01% | +25.0% |
| Q3 2014 | $508,000 | +5.0% | 7,920 | -0.4% | 0.01% | 0.0% |
| Q2 2014 | $484,000 | +1.7% | 7,955 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $476,000 | -2.9% | 7,955 | +3.5% | 0.01% | 0.0% |
| Q4 2013 | $490,000 | -7.2% | 7,685 | -1.1% | 0.01% | -20.0% |
| Q3 2013 | $528,000 | -7.2% | 7,770 | -1.6% | 0.01% | -9.1% |
| Q2 2013 | $569,000 | +29.6% | 7,900 | +6.0% | 0.01% | +22.2% |
| Q1 2013 | $439,000 | – | 7,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |